Clinuvel Pharmaceuticals | CUV - Operating Expenses

Stock Price
11.41
Daily Change
0.19 1.69%
Monthly
-4.60%
Yearly
-0.09%
Q1 Forecast
11.42

Clinuvel Pharmaceuticals reported AUD20.71M in Operating Expenses for its fiscal semester ending in June of 2024.





Operating Expenses Change Date
Avita Medical AUD 29.57M 1.21M Jun/2025
Medical Developments International AUD 10.02M 9.78M Jun/2025
Mesoblast USD 56.15M 32.57M Jun/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
Pacific Edge NZD 25.34M 2.03M Dec/2025
Paradigm Biopharmaceuticals AUD 8.49M 2.13M Jun/2025
PYC Therapeutics AUD 19.3M 19.28M Jun/2025
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025